• 28927 Citations
  • 84 h-Index
1981 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2007

Differences in the rate of lymph node invasion in men with clinically localized prostate cancer might be related to the continent of origin

Briganti, A., Shariat, S. F., Chun, F. K. H., Hutterer, G. C., Roehrborn, C., Gallina, A., Rigatti, P., Valiquette, L., Montorsi, F. & Karakiewicz, P. I., Sep 1 2007, In : BJU international. 100, 3, p. 528-532 5 p.

Research output: Contribution to journalArticle

26 Scopus citations
69 Scopus citations

Effects of alfuzosin 10 mg once daily on sexual function in men treated for symptomatic benign prostatic hyperplasia

Rosen, R., Seftel, A. & Roehrborn, C., Aug 1 2007, In : International Journal of Impotence Research. 19, 5, p. 480-485 6 p.

Research output: Contribution to journalArticle

27 Scopus citations

Evidence-based validation of the predictive value of the American Association for the Surgery of Trauma kidney injury scale

Shariat, S. F., Roehrborn, C., Karakiewicz, P. I., Dhami, G. & Stage, K. H., Apr 1 2007, In : Journal of Trauma - Injury, Infection and Critical Care. 62, 4, p. 933-939 7 p.

Research output: Contribution to journalArticle

81 Scopus citations

Examination of the Relationship Between Symptoms of Prostatitis and Histological Inflammation: Baseline Data From the REDUCE Chemoprevention Trial

Nickel, J. C., Roehrborn, C., O'Leary, M. P., Bostwick, D. G., Somerville, M. C. & Rittmaster, R. S., Sep 1 2007, In : Journal of Urology. 178, 3, p. 896-901 6 p.

Research output: Contribution to journalArticle

80 Scopus citations

Plasminogen Activation Inhibitor-1 Improves the Predictive Accuracy of Prostate Cancer Nomograms

Shariat, S. F., Park, S., Trinh, Q. D., Roehrborn, C. G., Slawin, K. M. & Karakiewicz, P. I., Oct 1 2007, In : Journal of Urology. 178, 4, p. 1229-1237 9 p.

Research output: Contribution to journalArticle

23 Scopus citations

Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy

Stephenson, A. J., Scardino, P. T., Kattan, M. W., Pisansky, T. M., Slawin, K. M., Klein, E. A., Anscher, M. S., Michalski, J. M., Sandler, H. M., Lin, D. W., Forman, J. D., Zelefsky, M. J., Kestin, L. L., Roehrborn, C., Catton, C. N., DeWeese, T. L., Liauw, S. L., Valicenti, R. K., Kuban, D. A. & Pollack, A., May 20 2007, In : Journal of Clinical Oncology. 25, 15, p. 2035-2041 7 p.

Research output: Contribution to journalArticle

656 Scopus citations

Prediction of Pathological Stage is Inaccurate in Men with PSA Values above 20 ng/mL

Gallina, A., Jeldres, C., Chun, F. K. H., Shariat, S. F., Briganti, A., Walz, J., Roehrborn, C., Saad, F., Huland, H., Graefen, M., Montorsi, F. & Karakiewicz, P. I., Nov 1 2007, In : European urology. 52, 5, p. 1374-1380 7 p.

Research output: Contribution to journalArticle

13 Scopus citations

Preoperative plasma HER2 and epidermal growth factor receptor for staging and prognostication in patients with clinically localized prostate cancer

Shariat, S. F., Bensalah, K., Karam, J. A., Roehrborn, C., Gallina, A., Lotan, Y., Slawin, K. M. & Karakiewicz, P. I., Sep 15 2007, In : Clinical Cancer Research. 13, 18, p. 5377-5384 8 p.

Research output: Contribution to journalArticle

24 Scopus citations

Prostate cancer disease-free survival after radical retropubic prostatectomy in patients older than 70 years compared to younger cohorts

Malaeb, B. S., Rashid, H. H., Lotan, Y., Khoddami, S. M., Shariat, S. F., Sagalowsky, A. I., McConnell, J. D., Roehrborn, C. & Koeneman, K. S., Jul 1 2007, In : Urologic Oncology: Seminars and Original Investigations. 25, 4, p. 291-297 7 p.

Research output: Contribution to journalArticle

29 Scopus citations

Prostate-Specific Antigen Improves the Ability of Clinical Stage and Biopsy Gleason Sum to Predict the Pathologic Stage at Radical Prostatectomy in the New Millennium

Chun, F. K. H., Briganti, A., Gallina, A., Hutterer, G. C., Shariat, S. F., Antebie, E., Walz, J., Roehrborn, C., Salonia, A., Rigatti, P., Saad, F., Huland, H., Montorsi, F., Graefen, M. & Karakiewicz, P. I., Oct 1 2007, In : European urology. 52, 4, p. 1067-1075 9 p.

Research output: Contribution to journalArticle

18 Scopus citations

Quantifying the Impact of Prostate Volumes, Number of Biopsy Cores and 5α-Reductase Inhibitor Therapy on the Probability of Prostate Cancer Detection Using Mathematical Modeling

Serfling, R., Shulman, M., Thompson, G. L., Xiao, Z., Benaim, E., Roehrborn, C. & Rittmaster, R., Jun 1 2007, In : Journal of Urology. 177, 6, p. 2352-2356 5 p.

Research output: Contribution to journalArticle

34 Scopus citations
10 Scopus citations

Tadalafil Relieves Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

McVary, K. T., Roehrborn, C., Kaminetsky, J. C., Auerbach, S. M., Wachs, B., Young, J. M., Esler, A., Sides, G. D. & Denes, B. S., Apr 1 2007, In : Journal of Urology. 177, 4, p. 1401-1407 7 p.

Research output: Contribution to journalArticle

280 Scopus citations

The benign prostatic hyperplasia registry and patient survey: Study design, methods and patient baseline characteristics

Roehrborn, C., Nuckolls, J. G., Wei, J. T. & Steers, W., Oct 2007, In : BJU international. 100, 4, p. 813-819 7 p.

Research output: Contribution to journalArticle

43 Scopus citations

The Effect of Doxazosin, Finasteride and Combination Therapy on Nocturia in Men With Benign Prostatic Hyperplasia

Johnson, T. M., Burrows, P. K., Kusek, J. W., Nyberg, L. M., Tenover, J. L., Lepor, H. & Roehrborn, C., Nov 1 2007, In : Journal of Urology. 178, 5, p. 2045-2051 7 p.

Research output: Contribution to journalArticle

66 Scopus citations

The Effect of Dutasteride on the Peripheral and Transition Zones of the Prostate and the Value of the Transition Zone Index in Predicting Treatment Response

Marks, L. S., Roehrborn, C., Wolford, E. & Wilson, T. H., Apr 1 2007, In : Journal of Urology. 177, 4, p. 1408-1413 6 p.

Research output: Contribution to journalArticle

30 Scopus citations

The VIOXX in prostate cancer prevention study: Cardiovascular events observed in the rofecoxib 25 mg and placebo treatment groups

Van Adelsberg, J., Gann, P., Ko, A. T., Damber, J. E., Logothetis, C., Marberger, M., Schmitz-Drager, B. J., Tubaro, A., Harms, C. J. & Roehrborn, C., Sep 1 2007, In : Current Medical Research and Opinion. 23, 9, p. 2063-2070 8 p.

Research output: Contribution to journalArticle

21 Scopus citations

Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy

Karam, J. A., Lotan, Y., Karakiewicz, P. I., Ashfaq, R., Sagalowsky, A. I., Roehrborn, C. & Shariat, S. F., Feb 1 2007, In : Lancet Oncology. 8, 2, p. 128-136 9 p.

Research output: Contribution to journalArticle

173 Scopus citations
2006
87 Scopus citations

Anthropometric and metabolic factors and risk of benign prostatic hyperplasia: A prospective cohort study of Air Force veterans

Gupta, A., Gupta, S., Pavuk, M. & Roehrborn, C., Dec 1 2006, In : Urology. 68, 6, p. 1198-1205 8 p.

Research output: Contribution to journalArticle

69 Scopus citations

Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo

Crawford, E. D., Wilson, S. S., McConnell, J. D., Slawin, K. M., Lieber, M. C., Smith, J. A., Meehan, A. G., Bautista, O. M., Noble, W. R., Kusek, J. W., Nyberg, L. M. & Roehrborn, C., Apr 2006, In : Journal of Urology. 175, 4, p. 1422-1427 6 p.

Research output: Contribution to journalArticle

146 Scopus citations
45 Scopus citations

Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 Ml or greater

Kaplan, S. A., McConnell, J. D., Roehrborn, C., Meehan, A. G., Lee, M. W., Noble, W. R., Kusek, J. W. & Nyberg, L. M., Jan 1 2006, In : Journal of Urology. 175, 1, p. 217-220 4 p.

Research output: Contribution to journalArticle

118 Scopus citations

Development of nomogram to predict acute urinary retention or surgical intervention, with or without dutasteride therapy, in men with benign prostatic hyperplasia

Slawin, K. M., Kattan, M. W., Roehrborn, C. & Wilson, T., Jan 1 2006, In : Urology. 67, 1, p. 84-88 5 p.

Research output: Contribution to journalArticle

15 Scopus citations

Dioxin exposure and benign prostatic hyperplasia

Gupta, A., Schecter, A., Aragaki, C. C. & Roehrborn, C., Jul 1 2006, In : Journal of Occupational and Environmental Medicine. 48, 7, p. 708-714 7 p.

Research output: Contribution to journalArticle

11 Scopus citations
7 Scopus citations

Efficacy and tolerability of tolterodine extended-release in men with overactive bladder and urgency urinary incontinence

Roehrborn, C., Abrams, P., Rovner, E. S., Kaplan, S. A., Herschorn, S. & Guan, Z., May 2006, In : BJU international. 97, 5, p. 1003-1006 4 p.

Research output: Contribution to journalArticle

65 Scopus citations

Enlarged prostate: A landmark national survey of its prevalence and impact on US men and their partners

Roehrborn, C., Marks, L. & Harkaway, R., Mar 1 2006, In : Prostate Cancer and Prostatic Diseases. 9, 1, p. 30-34 5 p.

Research output: Contribution to journalArticle

25 Scopus citations
7 Scopus citations

Pre-operative percent free psa predicts clinical outcomes in patients treated with radical prostatectomy with total PSA levels below 10 ng/ml

Shariat, S. F., Abdel-Aziz, K. F., Roehrborn, C. & Lotan, Y., Feb 1 2006, In : European urology. 49, 2, p. 293-302 10 p.

Research output: Contribution to journalArticle

26 Scopus citations

Prevention of Benign Prostatic Hyperplasia Disease

Marks, L. S., Roehrborn, C. & Andriole, G. L., Oct 1 2006, In : Journal of Urology. 176, 4, p. 1299-1306 8 p.

Research output: Contribution to journalArticle

33 Scopus citations

Relationship among serum testosterone, sexual function, and response to treatment in men receiving dutasteride for benign prostatic hyperplasia

Marberger, M., Roehrborn, C., Marks, L. S., Wilson, T. & Rittmaster, R. S., Apr 1 2006, In : Journal of Clinical Endocrinology and Metabolism. 91, 4, p. 1323-1328 6 p.

Research output: Contribution to journalArticle

43 Scopus citations

Serum dioxin, testosterone, and subsequent risk of benign prostatic hyperplasia: A prospective cohort study of Air Force Veterans

Gupta, A., Ketchum, N., Roehrborn, C., Schecter, A., Aragaki, C. C. & Michalek, J. E., Nov 2006, In : Environmental health perspectives. 114, 11, p. 1649-1654 6 p.

Research output: Contribution to journalArticle

41 Scopus citations

Significant upgrading affects a third of men diagnosed with prostate cancer: Predictive nomogram and internal validation

Chun, F. K. H., Briganti, A., Shariat, S. F., Graefen, M., Montorsi, F., Erbersdobler, A., Steuber, T., Salonia, A., Currlin, E., Scattoni, V., Friedrich, M. G., Schlomm, T., Haese, A., Michl, U., Colombo, R., Heinzer, H., Valiquette, L., Rigatti, P., Roehrborn, C., Huland, H. & 1 others, Karakiewicz, P. I., Aug 1 2006, In : BJU international. 98, 2, p. 329-334 6 p.

Research output: Contribution to journalArticle

99 Scopus citations

The cost of prostate cancer chemoprevention: A decision analysis model

Svatek, R. S., Lee, J. J., Roehrborn, C., Lippman, S. M. & Lotan, Y., Aug 2006, In : Cancer Epidemiology Biomarkers and Prevention. 15, 8, p. 1485-1489 5 p.

Research output: Contribution to journalArticle

24 Scopus citations
31 Scopus citations

Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: A randomized controlled trial

Kaplan, S. A., Roehrborn, C., Rovner, E. S., Carlsson, M., Bavendam, T. & Guan, Z., Nov 15 2006, In : Journal of the American Medical Association. 296, 19, p. 2319-2328 10 p.

Research output: Contribution to journalArticle

403 Scopus citations

Tolterodine extended release improves overactive bladder symptoms in men with overactive bladder and nocturia

Kaplan, S. A., Roehrborn, C., Dmochowski, R., Rovner, E. S., Wang, J. T. & Guan, Z., Aug 1 2006, In : Urology. 68, 2, p. 328-332 5 p.

Research output: Contribution to journalArticle

62 Scopus citations

Variability in the Performance of Nuclear Matrix Protein 22 for the Detection of Bladder Cancer

Shariat, S. F., Marberger, M. J., Lotan, Y., Sanchez-Carbayo, M., Zippe, C., Lüdecke, G., Boman, H., Sawczuk, I., Friedrich, M. G., Casella, R., Mian, C., Eissa, S., Akaza, H., Serretta, V., Huland, H., Hedelin, H., Raina, R., Miyanaga, N., Sagalowsky, A. I., Roehrborn, C. & 1 others, Karakiewicz, P. I., Sep 1 2006, In : Journal of Urology. 176, 3, p. 919-926 8 p.

Research output: Contribution to journalArticle

78 Scopus citations
2005

A double-blind placebo-controlled study evaluating the onset of action of doxazosin gastrointestinal therapeutic system in the treatment of benign prostatic hyperplasia

Roehrborn, C., Prajsner, A., Kirby, R., Andersen, M., Quinn, S. & Mallen, S., Sep 1 2005, In : European urology. 48, 3, p. 445-452 8 p.

Research output: Contribution to journalArticle

9 Scopus citations

Alfuzosin 10 mg once daily in the management of acute urinary retention: Results of a double-blind placebo-controlled study

McNeill, S. A., Hargreave, T. B. & Roehrborn, C. G., Jan 1 2005, In : Urology. 65, 1, p. 83-89 7 p.

Research output: Contribution to journalArticle

74 Scopus citations

Alpha2 macroglobulin, a PSA binding protein, is expressed in human prostate stroma

Lin, V. K., Wang, S. Y., Boetticher, N. C., Vazquez, D. V., Saboorian, H., McConnell, J. D. & Roehrborn, C., May 15 2005, In : Prostate. 63, 3, p. 299-308 10 p.

Research output: Contribution to journalArticle

13 Scopus citations

Benign prostatic hyperplasia

Chen, K. C., Peng, C. H., Wang, H. E., Peng, C. C., Peng, R. Y., Kaplan, S. A., Wang, W., Bergh, A., Damber, J. E., Benaim, E. A., Karam, J. A., Soboorian, M. H., Roehrborn, C., McConnell, J. D. & Lin, V., Apr 2005, In : Journal of Urology. 173, 4, p. 1266-1267 2 p.

Research output: Contribution to journalArticle

Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia

Shariat, S. F., Ashfaq, R., Roehrborn, C., Slawin, K. M. & Lotan, Y., Nov 2005, In : Journal of Urology. 174, 5, p. 2046-2050 5 p.

Research output: Contribution to journalArticle

35 Scopus citations

Idiopathic scrotal elephantiasis

Hornberger, B. J., Elmore, J. M. & Roehrborn, C., Feb 2005, In : Urology. 65, 2, p. 389.e14-389.e15

Research output: Contribution to journalArticle

18 Scopus citations

Implications of the prostate cancer prevention trial: A decision analysis model of survival outcomes

Lotan, Y., Cadeddu, J. A., Lee, J. J., Roehrborn, C. & Lippman, S. M., Dec 1 2005, In : Journal of Clinical Oncology. 23, 9, p. 1911-1920 10 p.

Research output: Contribution to journalArticle

28 Scopus citations

Long-term sustained improvement in symptoms of benign prostatic hyperplasia with the dual 5α-reductase inhibitor dutasteride: Results of 4-year studies

Roehrborn, C., Lukkarinen, O., Mark, S., Siami, P., Ramsdell, J. & Zinner, N., Sep 1 2005, In : BJU international. 96, 4, p. 572-577 6 p.

Research output: Contribution to journalArticle

50 Scopus citations

Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder

Shariat, S. F., Zippe, C., Lübecke, G., Boman, H., Sanchez-Carbayo, M., Casella, R., Mian, C., Friedrich, M. G., Eissa, S., Akaza, H., Sawczuk, I., Serretta, V., Huland, H., Hedelin, H., Rupesh, R., Miyanaga, N., Sagalowsky, A. I., Wians, F., Roehrborn, C., Lotan, Y. & 4 others, Perrotte, P., Benayoun, S., Marberger, M. J. & Karakiewicz, P. I., May 2005, In : Journal of Urology. 173, 5, p. 1518-1525 8 p.

Research output: Contribution to journalArticle

123 Scopus citations

Relationship between prostate specific antigen and indexes of prostate volume in Japanese men

Gupta, A., Aragaki, C., Gotoh, M., Masumori, N., Ohshima, S., Tsukamoto, T. & Roehrborn, C., Feb 2005, In : Journal of Urology. 173, 2, p. 503-506 4 p.

Research output: Contribution to journalArticle

32 Scopus citations